HRMY logo

HRMY Cash From Financing

Annual CFF

-$11.00 M
+$94.56 M+89.58%

December 31, 2024

Summary

Performance

1-Year Change

+89.58%

3-Year Change

-248.21%

5-Year Change

-107.65%

15-Year Change

-150.87%

HRMY Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

16.27%
HRMY annual cash flow from financing activities is higher than 16.27% of companies in Healthcare sector

High & Low

All-time High

$209.16 M
HRMY annual cash flow from financing activities is currently -105.26% below its historical high of $209.16 million

3-Year Low

-$105.55 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
HRMY previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
HRMY next annual earnings announcement has not yet been scheduled

OtherHRMYcash flowmetrics:

Annual CFI

-$67.48 M
HRMY annual cash flow from investing activities is -$67.48 million

Annual CFO

$219.82 M
HRMY annual cash flow from operations is $219.82 million

Annual FCF

$218.67 M
HRMY annual free cash flow is $218.67 million

Annual CAPEX

$1.15 M
HRMY annual capital expenditures is $1.15 million

Quarterly CFF

-$2.74 M
-$1.57 M-133.28%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

HRMY Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.55%
HRMY quarterly cash flow from financing activities is higher than 17.55% of companies in Healthcare sector

High & Low

All-time High

$136.62 M
HRMY quarterly cash flow from financing activities is currently -102.01% below its historical high of $136.62 million

3-Year Low

-$55.10 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
HRMY previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 30, 2025
HRMY next earnings announcement is scheduled for Apr 30, 2025

OtherHRMYcash flowmetrics:

Quarterly CFI

-$7.19 M
HRMY quarterly cash flow from investing activities is -$7.19 million

Quarterly CFO

$75.56 M
HRMY quarterly cash flow from operations is $75.56 million

Quarterly FCF

$75.05 M
HRMY quarterly free cash flow is $75.05 million

Quarterly CAPEX

$513.00 K
HRMY quarterly capital expenditures is $513.00 thousand

TTM CFF

-$11.00 M
+$50.78 M+82.20%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

HRMY TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

15.52%
HRMY TTM cash flow from financing activities is higher than 15.52% of companies in Healthcare sector

High & Low

All-time High

$234.53 M
HRMY TTM cash flow from financing activities is currently -104.69% below its historical high of $234.53 million

3-Year Low

-$115.70 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
HRMY previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 30, 2025
HRMY next earnings announcement is scheduled for Apr 30, 2025

OtherHRMYcash flowmetrics:

TTM CFI

-$67.48 M
HRMY TTM cash flow from investing activities is -$67.48 million

TTM CFO

$219.82 M
HRMY TTM cash flow from operations is $219.82 million

TTM FCF

$218.67 M
HRMY TTM free cash flow is $218.67 million

TTM CAPEX

$1.15 M
HRMY TTM capital expenditures is $1.15 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

HRMY Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+89.6%0.0%0.0%
3 y3 years-248.2%0.0%0.0%
5 y5 years-107.7%0.0%0.0%

HRMY Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-248.2%+89.6%-138.8%+95.0%-197.7%+90.5%
5 y5-year-105.3%+89.6%-102.0%+95.0%-104.7%+90.5%
alltimeall time-105.3%+89.6%-102.0%+95.0%-104.7%+90.5%

Harmony Biosciences Holdings Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
-$11.00 M(-89.6%)
-$2.74 M(+133.3%)
-$11.00 M(-82.2%)
Sep 2024
-
-$1.18 M(-65.9%)
-$61.78 M(-46.6%)
Jun 2024
-
-$3.45 M(-5.2%)
-$115.70 M(+2.8%)
Mar 2024
-
-$3.63 M(-93.2%)
-$112.59 M(+6.7%)
Dec 2023
-$105.55 M(-1642.9%)
-$53.52 M(-2.9%)
-$105.55 M(+113.8%)
Sep 2023
-
-$55.10 M(>+9900.0%)
-$49.37 M(-734.8%)
Jun 2023
-
-$339.00 K(-109.9%)
$7.78 M(-12.3%)
Mar 2023
-
$3.41 M(+28.3%)
$8.87 M(+29.6%)
Dec 2022
$6.84 M(-7.8%)
$2.66 M(+29.7%)
$6.84 M(-39.2%)
Sep 2022
-
$2.05 M(+173.3%)
$11.26 M(+26.6%)
Jun 2022
-
$750.00 K(-45.8%)
$8.89 M(+1.2%)
Mar 2022
-
$1.38 M(-80.4%)
$8.79 M(+18.5%)
DateAnnualQuarterlyTTM
Dec 2021
$7.42 M(-96.5%)
$7.07 M(-2359.4%)
$7.42 M(-1017.1%)
Sep 2021
-
-$313.00 K(-148.3%)
-$809.00 K(-100.6%)
Jun 2021
-
$648.00 K(+5300.0%)
$136.13 M(+0.5%)
Mar 2021
-
$12.00 K(-101.0%)
$135.41 M(-35.3%)
Dec 2020
$209.16 M(+45.5%)
-$1.16 M(-100.8%)
$209.16 M(-10.8%)
Sep 2020
-
$136.62 M(<-9900.0%)
$234.53 M(+59.8%)
Jun 2020
-
-$67.00 K(-100.1%)
$146.77 M(-26.4%)
Mar 2020
-
$73.76 M(+204.7%)
$199.31 M(+38.6%)
Dec 2019
$143.77 M(+565.1%)
$24.21 M(-50.5%)
$143.77 M(+20.2%)
Sep 2019
-
$48.87 M(-6.9%)
$119.56 M(+69.1%)
Jun 2019
-
$52.48 M(+188.1%)
$70.69 M(+288.1%)
Mar 2019
-
$18.22 M
$18.22 M
Dec 2018
$21.61 M
-
-

FAQ

  • What is Harmony Biosciences Holdings annual cash flow from financing activities?
  • What is the all time high annual CFF for Harmony Biosciences Holdings?
  • What is Harmony Biosciences Holdings annual CFF year-on-year change?
  • What is Harmony Biosciences Holdings quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Harmony Biosciences Holdings?
  • What is Harmony Biosciences Holdings quarterly CFF year-on-year change?
  • What is Harmony Biosciences Holdings TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Harmony Biosciences Holdings?
  • What is Harmony Biosciences Holdings TTM CFF year-on-year change?

What is Harmony Biosciences Holdings annual cash flow from financing activities?

The current annual CFF of HRMY is -$11.00 M

What is the all time high annual CFF for Harmony Biosciences Holdings?

Harmony Biosciences Holdings all-time high annual cash flow from financing activities is $209.16 M

What is Harmony Biosciences Holdings annual CFF year-on-year change?

Over the past year, HRMY annual cash flow from financing activities has changed by +$94.56 M (+89.58%)

What is Harmony Biosciences Holdings quarterly cash flow from financing activities?

The current quarterly CFF of HRMY is -$2.74 M

What is the all time high quarterly CFF for Harmony Biosciences Holdings?

Harmony Biosciences Holdings all-time high quarterly cash flow from financing activities is $136.62 M

What is Harmony Biosciences Holdings quarterly CFF year-on-year change?

Over the past year, HRMY quarterly cash flow from financing activities has changed by $0.00 (0.00%)

What is Harmony Biosciences Holdings TTM cash flow from financing activities?

The current TTM CFF of HRMY is -$11.00 M

What is the all time high TTM CFF for Harmony Biosciences Holdings?

Harmony Biosciences Holdings all-time high TTM cash flow from financing activities is $234.53 M

What is Harmony Biosciences Holdings TTM CFF year-on-year change?

Over the past year, HRMY TTM cash flow from financing activities has changed by $0.00 (0.00%)